[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.168.204. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 234
Citations 0
Capitol Health Call
February 8, 2012

FDA and Drug Shortages

JAMA. 2012;307(6):553. doi:10.1001/jama.2012.89

Congress should give the Food and Drug Administration (FDA) more power to help prevent, alleviate, and resolve drug shortages, according to the Government Accountability Office (GAO). The recommendation came in a report presented during a December 15 hearing by the Senate Committee on Health, Education, Labor, and Pensions.

In the report, the GAO indicated that even though the FDA has a drug shortage program, the agency is constrained in its ability to prevent shortages because it lacks the authority to require manufacturers to report actual or potential shortages or take actions to mitigate shortage situations (http://tinyurl.com/cc5t5ju).

First Page Preview View Large
First page PDF preview
First page PDF preview
×